ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)

STO:EXPRS2 Revenue

ExpreS2ion Biotech Holding AB had revenue of 3.42M SEK in the quarter ending June 30, 2025, with 42.46% growth. This brings the company's revenue in the last twelve months to 10.24M, up 26.49% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.

• Revenue (ttm): 10.24M
• Revenue Growth: +26.49%
• P/S Ratio: 5.89
• Revenue / Employee: 512.15K
• Employees: 18
• Market Cap: 60.37M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.83M	-974.00K	-11.07%
Dec 31, 2023	8.80M	2.65M	43.07%
Dec 31, 2022	6.15M	-7.58M	-55.21%
Dec 31, 2021	13.73M	-1.53M	-10.04%
Dec 31, 2020	15.26M	1.43M	10.37%